Tian D[au] - Search Results

Year	Number of Results
1982	1
1983	1
1985	1
1988	6
1989	5
1990	5
1991	10
1992	10
1993	3
1994	7
1995	3
1996	4
1997	3
1998	8
1999	8
2000	9
2001	13
2002	15
2003	16
2004	19
2005	30
2006	37
2007	44
2008	57
2009	44
2010	58
2011	76
2012	106
2013	144
2014	134
2015	164
2016	160
2017	178
2018	227
2019	266
2020	307
2021	198

1

Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China.

Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, Xie C, Ma K, Shang K, Wang W, Tian DS. Qin C, et al. Among authors: tian ds. Clin Infect Dis. 2020 Jul 28;71(15):762-768. doi: 10.1093/cid/ciaa248. Clin Infect Dis. 2020. PMID: 32161940 Free PMC article.

2

Hepatic complications of COVID-19 and its treatment.

Tian D, Ye Q. Tian D, et al. J Med Virol. 2020 Oct;92(10):1818-1824. doi: 10.1002/jmv.26036. Epub 2020 Jun 12. J Med Virol. 2020. PMID: 32437004 Free PMC article. Review.

3

Safety of peripheral administration of vasopressor medications: A systematic review.

Tian DH, Smyth C, Keijzers G, Macdonald SP, Peake S, Udy A, Delaney A. Tian DH, et al. Emerg Med Australas. 2020 Apr;32(2):220-227. doi: 10.1111/1742-6723.13406. Epub 2019 Nov 7. Emerg Med Australas. 2020. PMID: 31698544 Free article.

4

D-dimer level is associated with the severity of COVID-19.

Yu HH, Qin C, Chen M, Wang W, Tian DS. Yu HH, et al. Among authors: tian ds. Thromb Res. 2020 Nov;195:219-225. doi: 10.1016/j.thromres.2020.07.047. Epub 2020 Jul 27. Thromb Res. 2020. PMID: 32777639 Free PMC article.

5

Ultra-sensitive and high-throughput CRISPR-p owered COVID-19 diagnosis.

Huang Z, Tian D, Liu Y, Lin Z, Lyon CJ, Lai W, Fusco D, Drouin A, Yin X, Hu T, Ning B. Huang Z, et al. Among authors: tian d. Biosens Bioelectron. 2020 Sep 15;164:112316. doi: 10.1016/j.bios.2020.112316. Epub 2020 May 23. Biosens Bioelectron. 2020. PMID: 32553350 Free PMC article.

6

Immune suppression in the early stage of COVID-19 disease.

Tian W, Zhang N, Jin R, Feng Y, Wang S, Gao S, Gao R, Wu G, Tian D, Tan W, Chen Y, Gao GF, Wong CCL. Tian W, et al. Among authors: tian d. Nat Commun. 2020 Nov 17;11(1):5859. doi: 10.1038/s41467-020-19706-9. Nat Commun. 2020. PMID: 33203833 Free PMC article.

7

[Strategies for vaccine development of COVID-19].

Yang L, Tian D, Liu W. Yang L, et al. Among authors: tian d. Sheng Wu Gong Cheng Xue Bao. 2020 Apr 25;36(4):593-604. doi: 10.13345/j.cjb.200094. Sheng Wu Gong Cheng Xue Bao. 2020. PMID: 32347054 Free article. Review. Chinese.

8

Overview of cannabidiol (CBD) and its analogues: Structures, biological activities, and neuroprotective mechanisms in epilepsy and Alzheimer's disease.

Li H, Liu Y, Tian D, Tian L, Ju X, Qi L, Wang Y, Liang C. Li H, et al. Among authors: tian d. Eur J Med Chem. 2020 Apr 15;192:112163. doi: 10.1016/j.ejmech.2020.112163. Epub 2020 Feb 22. Eur J Med Chem. 2020. PMID: 32109623 Review.

9

Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients.

Ling Y, Xu SB, Lin YX, Tian D, Zhu ZQ, Dai FH, Wu F, Song ZG, Huang W, Chen J, Hu BJ, Wang S, Mao EQ, Zhu L, Zhang WH, Lu HZ. Ling Y, et al. Among authors: tian d. Chin Med J (Engl). 2020 May 5;133(9):1039-1043. doi: 10.1097/CM9.0000000000000774. Chin Med J (Engl). 2020. PMID: 32118639 Free PMC article.

10

Risk factors for viral RNA shedding in COVID-19 patients.

Fu Y, Han P, Zhu R, Bai T, Yi J, Zhao X, Tao M, Quan R, Chen C, Zhang Y, He Q, Jing M, Xiong X, Tian D, Yan W. Fu Y, et al. Among authors: tian d. Eur Respir J. 2020 Jul 2;56(1):2001190. doi: 10.1183/13993003.01190-2020. Print 2020 Jul. Eur Respir J. 2020. PMID: 32398298 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results